MRKR ▼ -0.8% - Marker Therapeutics, Inc. $MRKR - Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies Marker Therapeutics fell 0.8% today following news that the company has expanded manufacturing support from its CDMO partner in connection with the formation of Kincellis Advanced Therapies. The expansion of manufacturing capacity typically supports clinical or commercial scaling efforts, though the market's modest negative reaction suggests investors may be focused on timing, costs, or other strategic considerations not fully detailed in the announcement. 22-SEP-2026 08:01 AM ET